VIKING THERAPEUTICS INC's ticker is VKTXW and the CUSIP is 92686J114. A total of 5 filers reported holding VIKING THERAPEUTICS INC in Q3 2018. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $449,000 | +12.8% | 95,600 | 0.0% | 0.01% | +75.0% |
| Q4 2020 | $398,000 | -3.9% | 95,600 | 0.0% | 0.01% | -50.0% |
| Q3 2020 | $414,000 | -25.3% | 95,600 | 0.0% | 0.02% | -40.7% |
| Q2 2020 | $554,000 | +90.4% | 95,600 | 0.0% | 0.03% | +35.0% |
| Q1 2020 | $291,000 | -53.3% | 95,600 | 0.0% | 0.02% | -23.1% |
| Q4 2019 | $623,000 | +21.9% | 95,600 | 0.0% | 0.03% | +4.0% |
| Q3 2019 | $511,000 | -20.9% | 95,600 | 0.0% | 0.02% | -7.4% |
| Q2 2019 | $646,000 | -19.2% | 95,600 | 0.0% | 0.03% | -22.9% |
| Q1 2019 | $800,000 | +37.5% | 95,600 | 0.0% | 0.04% | +20.7% |
| Q4 2018 | $582,000 | -61.9% | 95,600 | 0.0% | 0.03% | -48.2% |
| Q3 2018 | $1,527,000 | +97.5% | 95,600 | 0.0% | 0.06% | +93.1% |
| Q2 2018 | $773,000 | +167.5% | 95,600 | 0.0% | 0.03% | +123.1% |
| Q1 2018 | $289,000 | +19.4% | 95,600 | 0.0% | 0.01% | +18.2% |
| Q4 2017 | $242,000 | +245.7% | 95,600 | 0.0% | 0.01% | +175.0% |
| Q3 2017 | $70,000 | +191.7% | 95,600 | 0.0% | 0.00% | +300.0% |
| Q2 2017 | $24,000 | -7.7% | 95,600 | +82.1% | 0.00% | -50.0% |
| Q1 2017 | $26,000 | – | 52,500 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Park West Asset Management LLC | 95,600 | $1,527,000 | 0.06% |
| BLAIR WILLIAM & CO/IL | 110,805 | $1,770,000 | 0.01% |
| UBS Group AG | 2,832 | $45,000 | 0.00% |
| US BANCORP \DE\ | 3,000 | $48,000 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |